Sherpa Healthcare Partners

Shanghai, China ยท DeepTech Native
Out of Scope

Bio

Sherpa Healthcare Partners Sherpa Healthcare Partners manages $400M+ across funds since 2016, with a cross- border focus linking China, the US, and global healthcare innovation. The team combines pharmaceutical industry experience with venture expertise, investing across biopharma, medical devices, diagnostics, and healthcare services. The fund has been particularly active in cell therapy, gene therapy, and precision medicine. advanced modalities where China's rapidly growing biotech sector is

Industries

BiotechMedTechSynthetic Biology

Stages

Series ASeries B+

Geography

US

Notable investments

  • InnoCare Pharma
  • GenScript subsidiary